Clinical trials
Phase 3 Alzheimer Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 7 |
| 2014 | 5 |
| 2015 | 3 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
| Terminated | 25 |
| Recruiting | 8 |
| Active, not recruiting | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 12 |
| Eli Lilly and Company | 7 |
| Pfizer | 6 |
| Biogen | 4 |
| Bristol-Myers Squibb | 4 |
| FORUM Pharmaceuticals Inc | 3 |
| H. Lundbeck A/S | 3 |
| TauRx Therapeutics Ltd | 3 |
| Axovant Sciences Ltd. | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 64 |
| Dementia | 15 |
| Cognitive Dysfunction | 6 |
| Amyloid Neuropathies, Familial | 5 |
| Neurodegenerative Diseases | 5 |
| Amyloidosis | 4 |
| Brain Diseases | 4 |
| Cardiomyopathies | 3 |
| Psychomotor Agitation | 3 |
| Central Nervous System Diseases | 2 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.